Nyxoah Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 154

Employees

  • Stock Symbol
  • NYXH

Stock Symbol

  • Share Price
  • $0.82
  • (As of Friday Closing)

Nyxoah General Information

Description

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Contact Information

Website
www.nyxoah.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Rue Edouard Belin 12
  • 1435 Mont-Saint-Guibert
  • Belgium
Primary Industry
Therapeutic Devices
Stock Exchange
BRU
Vertical(s)
Corporate Office
  • Rue Edouard Belin 12
  • 1435 Mont-Saint-Guibert
  • Belgium

Nyxoah Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nyxoah Stock Performance

As of 20-Nov-2026, Nyxoah’s stock price is $0.82. Its current market cap is $83.5M with 102M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.82 $0.88 $0.78 - $5.52 $83.5M 102M 239K -$1.83

Nyxoah Financials Summary

As of 30-Sep-2026, Nyxoah has a trailing 12-month revenue of $33.5M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 89,850 202,921 272,111 69,291
Revenue 33,532 11,303 4,892 4,705
EBITDA (96,837) (95,405) (59,873) (48,316)
Net Income (104,858) (101,616) (64,099) (46,759)
Total Assets 168,657 139,158 164,833 137,243
Total Debt 54,168 47,543 23,572 14,043
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nyxoah Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial

Nyxoah Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial

Nyxoah Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to t
Therapeutic Devices
Mont-Saint-Guibert, Belgium
154 As of 2025

Golden Valley, MN
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nyxoah Competitors (9)

One of Nyxoah’s 9 competitors is Inspire Medical Systems, a Formerly VC-backed company based in Golden Valley, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inspire Medical Systems Formerly VC-backed Golden Valley, MN
ResMed Corporation San Diego, CA
LivaNova Formerly VC-backed London, United Kingdom
Somnics Venture Capital-Backed Zhubei, Taiwan
Wellell Venture Capital-Backed New Taipei, Taiwan
You’re viewing 5 of 9 competitors. Get the full list »

Nyxoah Patents

Nyxoah Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026154037-A1 Implantable device for selective stimulation in peripheral nerves, and system using the implantable device in obstructive sleep apnea therapy Pending 17-Jan-2025
AU-2023232297-A1 Method and system for measuring a degree of muscle displacement and use of the method and system in treating obstructive sleep apnea Pending 11-Mar-2022
EP-4241674-A1 Method and system for measuring a degree of muscle displacement and use of the method and system in treating obstructive sleep apnea Active 11-Mar-2022
EP-4241674-B1 Method and system for measuring a degree of muscle displacement and use of the method and system in treating obstructive sleep apnea Active 11-Mar-2022
EP-4241674-C0 Method and system for measuring a degree of muscle displacement and use of the method and system in treating obstructive sleep apnea Active 11-Mar-2022 A61B5/0826
To view Nyxoah’s complete patent history, request access »

Nyxoah Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nyxoah Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial

Nyxoah ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Nyxoah’s complete esg history, request access »

Nyxoah FAQs

  • When was Nyxoah founded?

    Nyxoah was founded in 2009.

  • Where is Nyxoah headquartered?

    Nyxoah is headquartered in Mont-Saint-Guibert, Belgium.

  • What is the size of Nyxoah?

    Nyxoah has 154 total employees.

  • What industry is Nyxoah in?

    Nyxoah’s primary industry is Therapeutic Devices.

  • Is Nyxoah a private or public company?

    Nyxoah is a Public company.

  • What is Nyxoah’s stock symbol?

    The ticker symbol for Nyxoah is NYXH.

  • What is the current stock price of Nyxoah?

    As of 20-Nov-2026 the stock price of Nyxoah is $0.82.

  • What is the current market cap of Nyxoah?

    The current market capitalization of Nyxoah is $83.5M.

  • What is Nyxoah’s current revenue?

    The trailing twelve month revenue for Nyxoah is $33.5M.

  • Who are Nyxoah’s competitors?

    Inspire Medical Systems, ResMed, LivaNova, Somnics, and Wellell are some of the 9 competitors of Nyxoah.

  • What is Nyxoah’s annual earnings per share (EPS)?

    Nyxoah’s EPS for 12 months was -$1.83.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process